酸盐作为安全有效的替代氨酸用于导管锁定:随机对照试验的系统审查和元分析
Binbin Lai1,2, Weixing Huang2,3,4, Hui Yu2,5
1Department of Infection, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China.
Frontiers in medicine
|March 13, 2025
概括
与肝素相比,酸锁溶液显著减少了与导管相关的血液感染 (CRBSI). 这一元分析证实酸盐是导管治疗的安全有效替代品,特别是与抗生素一起使用.
科学领域:
- 医学研究 医学研究
- 传染性疾病 传染性疾病
- 临床药房 临床药房
背景情况:
- 关于最优的导管锁定溶液存在持续的辩论,其中酸盐和肝素是主要的药物.
- 导管相关的并发症对患者的安全性和治疗疗效构成重大风险.
研究的目的:
- 进行一项元分析,比较酸盐锁液与肝素锁液的疗效和安全性.
- 评估这些解决方案对预防导管相关并发症的影响.
主要方法:
- 按照PRISMA指南进行系统审查和元分析.
- 在PubMed,EMBASE,Medline和Cochrane图书馆搜索随机对照试验 (RCT).
- 分析了来自17个RCT的数据,涉及247,431个导管日,重点是CRBSI,CRI,ESI和不良事件.
主要成果:
- 与肝素相比,酸锁溶液显著降低了与导管相关的血液感染 (CRBSI) 的发生率 (RR:0.48).
- 当酸盐与抗生素结合使用或以低度使用时,这种益处更为明显.
- 在导管相关感染 (CRI),出口部位感染 (ESI),导管功能障碍或局部出血方面没有发现显著差异.
结论:
- 酸锁溶液是预防CRBSI的安全有效替代肝素.
- 酸盐不会增加全身凝血功能障碍或出血风险.
- 将酸盐锁液与抗生素结合起来,可以提高它们在预防CRBSI方面的有效性.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
586
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
586
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
78
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
78
Depolarizing Blockers: Pharmocokinetics
299
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
299
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
339
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
339
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K


